Wafik S. El-Deiry, Md, Phd, Facp Email & Phone Number
@brown.edu
5 phones found area 717, 215, and 347
LinkedIn matched
Who is Wafik S. El-Deiry, Md, Phd, Facp? Overview
A concise factual answer block for searchers comparing this professional profile.
Wafik S. El-Deiry, Md, Phd, Facp is listed as Chair at WIN Consortium in cancer personalized medicine, a company with 7 employees, based in Philadelphia, Pennsylvania, United States. AeroLeads shows a work email signal at brown.edu, phone signal with area code 717, 215, 347, and a matched LinkedIn profile for Wafik S. El-Deiry, Md, Phd, Facp.
Wafik S. El-Deiry, Md, Phd, Facp previously worked as Senior Member at National Academy Of Inventors and Director, Legorreta Cancer Center at Brown University at Brown University. Wafik S. El-Deiry, Md, Phd, Facp holds Medical And Postdoctoral Training, Medicine Residency And Medical Oncology Fellowship from The Johns Hopkins University School Of Medicine.
Email format at WIN Consortium in cancer personalized medicine
This section adds company-level context without repeating Wafik S. El-Deiry, Md, Phd, Facp's masked contact details.
AeroLeads found 1 current-domain work email signal for Wafik S. El-Deiry, Md, Phd, Facp. Compare company email patterns before reaching out.
About Wafik S. El-Deiry, Md, Phd, Facp
Wafik El-Deiry, MD, PhD, FACP an American Cancer Society Research Professor, is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. He was previously Deputy Director & Program Leader at Fox Chase Cancer Center, Rose Dunlap Professor of Medicine & Chief of Hematology/Oncology, and Interim Director at Penn State Cancer Institute. Dr. El-Deiry joined University of Pennsylvania as Assistant Professor of Medicine & Genetics in 1994, was promoted to Associate Professor with tenure in 1999 & Professor of Medicine, Pharmacology & Genetics with tenure in 2005. He was an Investigator of the Howard Hughes Medical Institute from 1995-2004. He served as co-Leader of the Radiobiology & Imaging Program at the Abramson Cancer Center & Associate Director for Physician-Scientist Training in Hem/Onc at UPenn. He earned MD & PhD degrees at University of Miami & completed medicine residency & oncology fellowship at Johns Hopkins. Dr. El-Deiry discovered p21(WAF1) as p53 target gene, cell cycle inhibitor, & tumor suppressor that explained the mammalian cell stress response. This was the most highly cited original work published in Cell. He discovered TRAIL receptor DR5 as p53 target, & ONC201/TIC10 as TRAIL pathway, integrated stress response inducer & cancer therapeutic with efficacy in diffuse midline glioma & other tumors.Dr. El-Deiry has >500 publications & edited 6 books. He has served on editorial boards including as Associate Editor for the Journal of Clinical Investigation from 2007-2010 and Editor-in-Chief of Cancer Biology & Therapy from 2001 to 2019. He is active as an NCI grant reviewer, has served on ACS Council, lectures widely & is a highly cited researcher (H-index 128 in 2024 with > 103,000 citations in Google Scholar). He was named one of America's Top Oncologists by Consumer Res Council of America in 2008 & 2009. He is a member of Faculty of 1000 (Faculty Opinions), Interurban Clinical Club (President, 2013-2014), American Society of Clinical Investigation (ASCI) & Association of American Physicians (AAP). He organized international meetings & won 2009 Kuwait International Prize in Applied Sciences. He founded Oncoceutics in 2004 (acquired by Chimerix in 2021), p53-Therapeutics, and SMURF-Therapeutics. He became a member of the Johns Hopkins University Society of Scholars in 2014. He received the inventor of the year award from Brown University in 2022 and 2023. He is a practicing physician-scientist specializing in colorectal cancer treatment & precision oncology.
Listed skills include Oncology, Clinical Trials, Genetics, Translational Research, and 45 others.
Wafik S. El-Deiry, Md, Phd, Facp's current company
Company context helps verify the profile and gives searchers a useful next step.
Wafik S. El-Deiry, Md, Phd, Facp work experience
A career timeline built from the work history available for this profile.
Senior Member
Current
Chair
CurrentRead my guest editorial in the December 8, 2023 issue of The Cancer Letter:New leadership, vision for the Worldwide Innovative Network Consortium in precision oncologyhttps://cancerletter.com/guest-editorial/20231208_3/
Director, Legorreta Cancer Center At Brown University
Currenthttps://www.brown.edu/news/2021-12-09/legorreta
Director, Cancer Center At Brown University (Renamed Legorreta Cancer Center In December, 2021)
Current
Mencoff Family Endowed University Professor Of Medical Science
Current
Professor Of Pathology And Laboratory Medicine With Tenure At Brown University
Current
Director, Joint Program In Cancer Biology
Current
Elected Member, Faculty Executive Committee Of Brown University
Served as an Elected Member of Brown University’s Faculty Executive Committee (FEC), the only representative from The Warren Alpert Medical School at Brown. During this period, I also served as the FEC Representative to the Medical Faculty Executive Committee (MFEC) at The Warren Alpert Medical School.
Editor In Chief
Current
Editorial Board
CurrentI joined the Editorial Board of Oncotarget in 2010. In June of 2024 I started serving as Editor-in-Chief.
Founder And Ceo
CurrentSMURF-Therapeutics, Inc. is developing small molecule therapeutics to activate or block Smurf2 for cancer, anemia and wound healing. The company was founded by Wafik El-Deiry, MD, PhD, FACP in 2021 while at Brown University to develop small molecule compounds targeting hypoxia responses based on numerous academic research papers and reviews published over.
Founder And Chairman
Currentp53-Therapeutics, Inc. is developing a new class of small molecule cancer therapeutics to effectively bypass mutations in the p53 tumor suppressor gene to treat patients with cancer.
Boat Captain
CurrentWhile I grew up in South Florida and have been on the water as an untrained captain of small boats or as a passenger on large cruise ships, during COVID I received several hours of training through Freedom Boat Club of Rhode Island to Captain small motor boats. I later received private lessons from experienced boat captains in Rhode Island for training on.
Associate Dean For Oncologic Sciences
Current
Director, Laboratory Of Translational Oncology And Experimental Cancer Therapeutics
Current
Director, Joint Program In Cancer Biology At Brown And Lifespan
Current
Attending Physician, Hematology/Oncology; Member, Rhode Island Hospital Medical Staff
CurrentActive Medical Staff with admitting privileges at the Rhode Island Hospital and The Miriam Hospital in Providence, Rhode Island. Colorectal Cancer Clinic at the Lifespan Cancer Institute.
American Cancer Society Research Professor
CurrentConduct basic and translational research on cancer. Discover and develop new treatments for cancer. Work on personalizing cancer therapy. Collaborate with other basic scientists and clinicians to bring the latest scientific advances to patients. Promote the careers of younger scientists. Support the work of the American Cancer Society. Inform the public.
President, Secretary-Treasurer, Councilor (Philadelphia), And Member
CurrentPresident (2013-2014)Secretary-Treasurer (2008-2013)Councilor for Philadelphia (2007-2009)Member (2005-Present)
Founder
Current
Adjunct Professor Of Medical Oncology
Current
William Wikoff Smith Endowed Chair In Cancer Research
Co-Program Leader In Molecular Therapeutics
Deputy Cancer Center Director For Translational Research
Professor Of Medical Oncology
Provide clinical care to patients with colorectal cancer. Conduct basic and clinical research in the area of novel targeted treatments for patients with cancer. Direct a translational oncology research laboratory. Secure funding to support research activities. Mentor graduate students, post-doctoral and clinical fellows and junior faculty.
Clinical Professor Of Medicine
CurrentEditor-In-Chief
Dr. El-Deiry is the founding Editor-in-Chief of the international peer-reviewed journal Cancer Biology and Therapy. The goal of the journal has always been to provide high quality high impact advances in the field of cancer research and translational medicine as it applies to cancer. An ongoing major goal is to continuously improve the impact and attract.
Adjunct Professor Of Pharmacology
Develop collaborative projects and joint grant submissions with colleagues at the University of Pennsylvania. Build interdisciplinary and inter-institutional relationships for joint initiatives.
Member, Md-Phd Internal Advisory Committee
Clinical Member, Conflict Of Interest Review Committee
Rose Dunlap Professor Of Medicine And Chief, Hematology/Oncology Division
Led the large combined Division of Hematology/Oncology at Penn State University, Penn State College of Medicine, and the Penn State Hershey Cancer Institute that in 2010 had 28 faculty members, in 2012 had 35 faculty member and in 2014 had 40 faculty members. Recruited, mentored, developed, & promoted the careers of division faculty who are experts in.
Associate Director For Translational Research
Built bridges between clinicians & clinical investigators in the disciplines of medical oncology, radiation oncology, surgical oncology, pathology, radiology & the basic research disciplines including basic science departments, basic cancer institute programs at the Penn State Cancer Institute, the Institute for Personalized Medicine & CTSA at Penn State..
Interim Director, Penn State Hershey Cancer Institute
Adjunct Professor Of Medicine
Associate Director For Physician-Scientist Training In Hematology/Oncology
Provided career counseling and mentoring to Hematology/Oncology Fellows at the University of Pennsylvania through individual meetings as well as committee meetings. Supported recruitment efforts for the fellowship program of the Division of Hematology/Oncology at the University of Pennsylvania. Provided guidance to Hematology/Oncology Fellows on grant.
Member, Md-Phd Admissions Committee
Professor Of Medicine, Genetics, And Pharmacology
Directed a large and very productive cancer research lab focused on cell death signaling pathways, molecular imaging, animal model development, drug discovery and development. Fostered career development of trainees including graduate students, medical students, house staff and clinical fellows. Developed graduate level courses in Cell Cycle and Cancer, as.
Chair, Admissions Committee, Cell Growth And Cancer Graduate Program
Member, Institutional Review Board
Co-Program Leader, Radiobiology & Imaging Program
Organized regular Radiobiology & Imaging Program meetings and retreats at the Abramson Cancer Center. Attended program meetings and retreats and led discussions to promote basic and translational research efforts in radiobiology research and the field of molecular imaging. Developed interactions between basic and clinical departments and between basic and.
Attending Physician (Solid Tumor Oncology)
Provided both inpatient and outpatient care to patients with cancer at the Hospital of the University of Pennsylvania, and the Philadelphia VA Hospital.
Investigator
http://www.hhmi.org/research/investigators/eldeiry_bio.html
Wafik S. El-Deiry, Md, Phd, Facp education
Medical And Postdoctoral Training, Medicine Residency And Medical Oncology Fellowship
Md/Phd Program, Md Doctor Of Medicine, Phd Degree In Biochemistry
Medicine Sub-Internship At Beth Israel Hospital, Internal Medicine
Bs, Chemistry/Math
Education record
Education record
Master Of Arts - Ma
Master Of Arts - Ma
Frequently asked questions about Wafik S. El-Deiry, Md, Phd, Facp
Quick answers generated from the profile data available on this page.
What company does Wafik S. El-Deiry, Md, Phd, Facp work for?
Wafik S. El-Deiry, Md, Phd, Facp works for WIN Consortium in cancer personalized medicine.
What is Wafik S. El-Deiry, Md, Phd, Facp's role at WIN Consortium in cancer personalized medicine?
Wafik S. El-Deiry, Md, Phd, Facp is listed as Chair at WIN Consortium in cancer personalized medicine.
What is Wafik S. El-Deiry, Md, Phd, Facp's email address?
AeroLeads has found 1 work email signal at @brown.edu for Wafik S. El-Deiry, Md, Phd, Facp at WIN Consortium in cancer personalized medicine.
What is Wafik S. El-Deiry, Md, Phd, Facp's phone number?
AeroLeads has found 5 phone signal(s) with area code 717, 215, 347 for Wafik S. El-Deiry, Md, Phd, Facp at WIN Consortium in cancer personalized medicine.
Where is Wafik S. El-Deiry, Md, Phd, Facp based?
Wafik S. El-Deiry, Md, Phd, Facp is based in Philadelphia, Pennsylvania, United States while working with WIN Consortium in cancer personalized medicine.
What companies has Wafik S. El-Deiry, Md, Phd, Facp worked for?
Wafik S. El-Deiry, Md, Phd, Facp has worked for Win Consortium In Cancer Personalized Medicine, National Academy Of Inventors, Brown University, Oncotarget, and Smurf-Therapeutics, Inc..
Who are Wafik S. El-Deiry, Md, Phd, Facp's colleagues at WIN Consortium in cancer personalized medicine?
Wafik S. El-Deiry, Md, Phd, Facp's colleagues at WIN Consortium in cancer personalized medicine include Fanny Wunder.
How can I contact Wafik S. El-Deiry, Md, Phd, Facp?
You can use AeroLeads to view verified contact signals for Wafik S. El-Deiry, Md, Phd, Facp at WIN Consortium in cancer personalized medicine, including work email, phone, and LinkedIn data when available.
What schools did Wafik S. El-Deiry, Md, Phd, Facp attend?
Wafik S. El-Deiry, Md, Phd, Facp holds Medical And Postdoctoral Training, Medicine Residency And Medical Oncology Fellowship from The Johns Hopkins University School Of Medicine.
What skills is Wafik S. El-Deiry, Md, Phd, Facp known for?
Wafik S. El-Deiry, Md, Phd, Facp is listed with skills including Oncology, Clinical Trials, Genetics, Translational Research, Hematology, Administration, Editorial Skills, and Molecular Oncology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial